Application of PDT for Uterine Cervical Cancer

Area of Science:

• Gynecology
• Oncology
• Photomedicine

Background:

• Cervical dysplasia and early-stage cervical cancers require effective, fertility-sparing treatments.
• Photodynamic therapy (PDT) offers a minimally invasive approach.
• Low-power lasers provide enhanced tissue penetration compared to traditional methods.

Purpose of the Study:

• To evaluate the efficacy and safety of PDT for cervical and vulvar dysplasia.
• To assess the long-term outcomes and fertility preservation with PDT.

Main Methods:

• PDT administered 48 hours post-intravenous injection of 1.5-2.0 mg/kg Photofrin (PHE).
• Treatment utilized Excimer Dye Laser (EDL) or YAG-OPO lasers with colposcopic or cervical probe-guided irradiation.
• 131 patients with various stages of cervical dysplasia, vulvar dysplasia, and early cervical cancers were treated.

Main Results:

• A complete response (CR) rate of 96.9% (127 out of 131 cases) was achieved.
• No recurrence observed in the first CR case over a 10-year follow-up period.
• PDT demonstrated excellent fertility preservation with no significant complications during pregnancy or delivery.

Conclusions:

• PDT is a highly effective, minimally invasive, and fertility-sparing treatment for cervical dysplasia and early cervical cancers.
• Low-power lasers (EDL, YAG-OPO) offer superior tissue penetration for PDT.
• Future advancements may involve diode lasers and shorter-acting photosensitizers for outpatient PDT.